Cannabis Law Report

OCTOBER 17, 2019

Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market. The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JUNE 8, 2021

This SRA will leverage four other clinical trials being planned by the university, to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

MMJ Recs

DECEMBER 22, 2023

As the United States navigates through a complex web of legal, social, and medical considerations, public opinion on medical cannabis has evolved significantly over the years. The changing public opinion is evident in the increasing number of states legalizing medical cannabis and the growing support for such measures.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War.

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Weedistry

JANUARY 28, 2019

Ontario-based Oriol Rhodes has over 30 years of experience in the healthcare industry, but it’s only recently that she has ventured into an uncharted territory: cannabis. “A Can medical cannabis be the solution? The first conversation opened with Chamberland thinking the family would be dead-set against the use of medicinal cannabis.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Cannabis Law Report

JULY 4, 2021

CLR contributor, Brian Cusack, writes… The legalization of cannabis in Ireland has become a popular discussion around the world. While countries like Canada, Uruguay, and some states in America have legalized recreational cannabis, this isn’t a trend that has reached Ireland yet. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

CannaTech

MARCH 24, 2019

Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. Some of the most recognized applications of cannabinoid-based medicine are in the treatment of neuropathic pain , inflammation and muscle spasticity. These attitudes, however, are changing.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

The Joint Blog

APRIL 17, 2020

According to a new study in the Journal of Clinic Medicine , the use of Tetrahydrocannabinol (THC) could have adverse drug effects when combined with other medications due to drug-drug interactions. Cannabis Sativa, a.k.a Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia.

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JULY 9, 2021

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

NORML

JANUARY 18, 2019

Representative Lou Correa (D-CA) this week introduced HR 493: The Sensible Enforcement Of Cannabis Act, which would codify the protections that were outlined in the now-rescinded Cole Memo. House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis.

Legislation 160

Legislation Decriminalization Access Therapy 160

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. “The 1mg dose showed a significant pain decrease compared to the placebo. .”

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

Cannabis Law Report

JUNE 11, 2019

This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. These claims have occurred against a background of significant change with regards to the acceptance of cannabis, both medically and recreationally. Awards for Cannabis as a Future Care Cost.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

The Joint Blog

OCTOBER 21, 2020

With the rise in popularity of cannabis lately, there are still many questions regarding its legality. After the Agriculture Act of 2018 was reauthorized, hemp, a species of the cannabis plant, has been legalized on the federal level. The effects of THC responsible for the cannabis high. THC trace content by dry weight.

CBD 36

CBD Legalization Oil Hemp 36

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Altasciences helps sponsors get better drugs to the people who need them, faster.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 108

Programs Research and Development Education Treatment 108

Project CBD

MAY 3, 2023

This transcript is adapted from CannMed’s weekly podcast , hosted by Ben Amirault, who recently interviewed Bonni Goldstein, MD, one of the country’s most respected and experienced medical cannabis physicians. Dr. Goldstein has treated thousands of patients with medical cannabis. CBG is not intoxicating or impairing.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 40

Programs Research and Development Education Treatment 40

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

The Cannigma

MARCH 12, 2021

Listen & Subscribe: Very few medical cannabis advocates are against the full legalization of the plant for all adults. In this episode of The Cannabis Enigma Podcast, host Michael Schaeffer Omer-Man interviews Dr. Fisher about the various ways medical and adult-use cannabis markets interact. Dr. Ruth Fisher. Music by Desca.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. THC, the primary psychoactive component of cannabis. The cannabis oil is made out of extract from the Avidekel strain and olive oil.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

CannaMD

NOVEMBER 8, 2019

While VA doctors can’t prescribe or recommend medical marijuana ( that’s what we do ), they also can’t withhold benefits because you’re a medical cannabis patient. According to the VA : Veteran participation in state marijuana programs does not affect eligibility for VA care and services.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. 9-THC, the primary psychoactive component of cannabis. Cannabis oil: TO Pharmaceuticals. One World Cannabis. Dronabinol.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. The SAFE Banking Act (H.R.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 20, 2021

The CBD brand FullSend claims Nelk has conducted an “enforcement program” to put it out of business by threatening it with litigation and demanding it stop selling and advertising its products under what FullSend claims is its own mark. NORML warns consumers to only obtain Delta-8 products from state-regulated cannabis manufacturers.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. And the safety and efficacy of those drugs aren’t even buttressed by a mountain of anecdotal evidence — unlike cannabis use, which has thousands of years of documentation. That’s simply not true.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. This white paper offers a primer to the complex and confusing global cannabis industry as it stands today.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. Cannabis reform has stalled recently because of opposition from Kentucky’s Senate leadership. Danny Bentley, R-Russell, erroneously compared cannabis to “snake oil remedies of the 1800s,” according to a WDRB-TV report.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JUNE 30, 2019

In this week’s edition: The US House passes bipartisan measure to prevent the Department of Justice from interfering with state medical and adult-use cannabis laws. The Delaware Senate passes legislation making violation of cannabis consumption/possession laws by minors a civil rather than criminal infraction.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

NORML write, “2019 has been a monumental year for cannabis reform across the United States. Over 60 cannabis-related bills were signed into law in states across the country. Now, nearly 1 in 4 Americans reside in a jurisdiction where the adult use of cannabis is legal, and 33 states regulate medical marijuana access.

Legislation 59

Legislation Patients Access Banking 59